Randomized Phase III Trial of Ixabepilone Plus Capecitabine Versus Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane

PURPOSE: We sought to determine whether the combination of ixabepilone plus capecitabine improved overall survival (OS) compared with capecitabine alone in patients with metastatic breast cancer (MBC) previously treated with anthracyclines and taxanes. PATIENTS AND METHODS: A total of 1,221 patients...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Sparano, Joseph A., Vrdoljak, Eduard, Rixe, Oliver, Xu, Binghe, Manikhas, Alexey, Medina, Carlos, Ventilari Da Costa, Susanne Crocamo, Ro, Jungsil, Rubio, Gonzalo, Rondinon, Monica, Perez Manga, Gumersindo, Peck, Ronald, Poulart, Valerie, Conte, Pierfranco
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Clinical Oncology 2010
Pynciau:
Original Reports
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2903325/
https://ncbi.nlm.nih.gov/pubmed/20530276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.24.4244
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg